Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: Technored who wrote (3469)	10/31/2002 3:10:55 PM
From: fred hayes	Read Replies (1) \| Respond to of 10345

Thanks. Saw that some time ago, but thought some of the drug values were too low. Think of my analysis as trying to update their material. I used somewhat higher prices on the drugs consistent with a prior post on this board by Robohogs back in Feb. Some other values like cash and debt came from Elan's 9/30 release. Also, I tried to put some value on the pipeline, which wasn't considered in the LYONS estimates. By the way, I did use 350 million shares in my per share calcs, not the 150 million I indicated in the post. I'm hoping we'll get some input to revise and firm-up the numbers I used.